Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BGI Will Acquire Complete Genomics

by Michael McCoy
September 24, 2012 | A version of this story appeared in Volume 90, Issue 39

China’s BGI-Shenzhen will acquire California-based Complete Genomics in a transaction that the companies value at $118 million. BGI, once known as Beijing Genomics Institute, operates a nonprofit research institute and a commercial gene-sequencing business. Complete Genomics, which said in June that it might put itself up for sale, provides whole human genome sequencing. BGI CEO Wang Jun says the two companies have complementary expertise and R&D capabilities.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.